Lori M. Brandes, Ph.D., is an of counsel in Sterne Kessler's Biotechnology/Chemical Practice Group.
Lori counsels domestic and international clients on the preparation, prosecution, and management of complex worldwide patent portfolios. She is also experienced in technology transfer, invalidity, noninfringement, freedom-to-operate and patentability opinions, and due diligence investigations. Specifically, she works with clients to obtain and enforce patents in areas such as biotechnology, immunology, biofuels, pharmaceuticals, and food science. Lori has also been involved in U.S. patent interference and litigation matters, as well as foreign oppositions.
Lori is a contributing author of Patent Office Litigation, Second Edition, published in 2017, and the two-volume set Patent Office Litigation, published in 2012 by Thomson Reuters Westlaw. The first edition focused on the new contested proceedings under the America Invents Act that year, while the second edition provides a fresh and comprehensive exploration of these proceedings. Both books examine how the proceedings interact with other aspects of patent procurement and enforcement, and deliver practical analysis and advice.
Lori earned her J.D. from the University of Maryland Francis King Carey School of Law, her Ph.D. in pharmacology from The George Washington University, and her B.A. in biochemistry and molecular, cellular and developmental biology from the University of Colorado.
- Brandes LM, Lin ZP, Patierno SR, Kennedy KA. Reversal of physiological stress-induced resistance to topoisomerase II inhibitors using an inducible phosphorylation site-deficient mutant of IkappaBalpha. Mol. Pharmacol. 60:559-67, 2001
- Boller YC, Brandes LM, Russell RL, Lin ZP, Patierno SR, Kennedy KA. Prostaglandin A1 inhibits stress-induced NF-kappaB activation and reverses resistance to topoisomerase II inhibitors. Oncol. Res. 12:383-95, 2000